PIK3R5 and acute myeloid leukemia: Overall, this study provides a proof of concept for targeting gene dependency via PI3Kγ to treat the PIK3R5-restricted monocytic lineage of AML and provides novel strategies for synergizing conventional therapies to overcome chemoresistance.